Asia-Pacific dermal fillers market is projected to register a substantial CAGR in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation:
Asia-Pacific Dermal Fillers Market, By Type (Semi-Permanent Dermal Filler, Permanent Dermal Filler), Product Type (Biodegradable Dermal Fillers, Non-Biodegradable Dermal Fillers), Application (Facial Line Correction, Wrinkles, Face Lift, Lip Enhancement, Scar Treatment, Rhinoplasty, Sagging Skin, Cheek Depression, Dentistry, Reconstructive Surgery, Aesthetic Restoration, Others), Material Type (Natural Dermal Fillers, Synthetic Dermal Fillers), Drug Type (Branded, Generic), End User (Dermatology Clinics, Ambulatory Surgical Centers, Hospitals, others), Distribution Channel (Drug Stores, Retail Pharmacy, Online Pharmacies), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) - Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the market are:

- Rising demand for anti-aging drugs
- Growing popularity of aesthetics procedures

Market Players:

The key market players for Asia-Pacific dermal fillers market are listed below:

- Suneva Medical
- Teoxane
- Croma-Pharma GmbH
- SCULPT Luxury Dermal Fillers LTD
- Sinclair Pharma (A Subsidiary of Huadong Medicine Co., Ltd.)
- Anika Therapeutics, Inc.
- BIOXIS Pharmaceuticals
- BioPlus Co., Ltd.
- Zhejiang Jingjia Medical Technology Co.,Ltd.
- Galderma Laboratories, L.P.
- Merz Pharma
- Allergan
- Prollenium Medical Technologies
- Bioha Laboratories
- Contura Ltd.
- Humedix.CO.LTD (Subsidiary of Huons Asia-Pacific)